Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search
Fullscreen

For citation:


Avxentyev N.A., Frolov M.Y., Makarov A.S. Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2018;11(2):27-37. (In Russ.) https://doi.org/10.17749/2070-4909.2018.11.2.027-037

Views: 81


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)